The spinal cord acts as a highway that transports electrical signals from your brain to the rest of your body through long bundles of nerve fibers. It allows your brain to communicate with the rest of your body to coordinate movement and reflexes and to receive sensory information. When the spinal cord is damaged, the … Continue reading Getting On Tract: Stem Cells Regenerate Injured Spinal Cord in Rats
Translational research
Rare disease underdogs come out on top at CIRM Board meeting
It seems like an oxymoron but one in ten Americans has a rare disease. With more than 7,000 known rare diseases it’s easy to see how each one could affect thousands of individuals and still be considered a rare or orphan condition. Only 5% of rare diseases have FDA approved therapies People with rare … Continue reading Rare disease underdogs come out on top at CIRM Board meeting
Scientists use cotton candy to make artificial blood vessels
Cotton candy gets a bad rap. The irresistible, brightly colored cloud of sugar is notorious for sending kids into hyperactive overdrive and wreaking havoc on teeth. While it’s most typically found at a state fair or at a sports stadium, cotton candy is now popping up at the lab bench and is re-branding itself into … Continue reading Scientists use cotton candy to make artificial blood vessels
If you want to accelerate stem cell therapies then create an Accelerating Center
“You can’t teach fish to fly,” is one of the phrases that our CIRM President & CEO, Randy Mills, likes to throw out when asked why we needed to create new centers to help researchers move their most promising therapies out of the lab and into clinical trials. His point is that many researchers are … Continue reading If you want to accelerate stem cell therapies then create an Accelerating Center
Protective cell therapy could mean insulin independence for diabetic patients
This has already been a productive year for diabetes research. Earlier this month, scientists from UCSF and the Gladstone Institutes successfully made functional human pancreatic beta cells from skin, providing a new and robust method for generating large quantities of cells to replace those lost in patients suffering from type 1 diabetes. Today marks another … Continue reading Protective cell therapy could mean insulin independence for diabetic patients
A Win for Diabetes: Scientists Make Functional Pancreatic Cells From Skin
Today is an exciting day for diabetes research and patients. For the first time, scientists have succeeded in making functional pancreatic beta cells from human skin. This new method for making the insulin-producing cells of the pancreas could produce a new, more effective treatment for patients suffering from diabetes. Researchers at the Gladstone Institutes and … Continue reading A Win for Diabetes: Scientists Make Functional Pancreatic Cells From Skin
CIRM Scholar Spotlight: Berkeley’s Maroof Adil on stem cell transplants for Parkinson’s disease
Stem cell therapy has a lot of potential for Parkinson’s patients and the scientists that study it. One of our very own CIRM scholars, Maroof Adil, is making it his mission to develop stem cell based therapies to treat brain degenerating diseases like Parkinson’s. Maroof got his undergraduate degrees from MIT in both Chemical Engineering … Continue reading CIRM Scholar Spotlight: Berkeley’s Maroof Adil on stem cell transplants for Parkinson’s disease
From Stem Cells to Cures with Shinya Yamanaka and Google Ventures
How do you go from basic stem cell research to cures for patients? We ask this question everyday at CIRM, and we’re not alone in our tireless pursuit to find answers to this challenging question. In fact, two leaders on different sides of the stem cell arena - research and investment - came together last … Continue reading From Stem Cells to Cures with Shinya Yamanaka and Google Ventures
The Ogawa-Yamanaka Prize Crowns Its First Stem Cell Champion
A world of dark Imagine if you woke up one day and couldn’t see. Your life would change drastically, and you would have to painfully relearn how to function in a world that heavily relies on sight. While most people don’t lose their sight overnight, many suffer from visual impairments that slowly happen over time. … Continue reading The Ogawa-Yamanaka Prize Crowns Its First Stem Cell Champion
CIRM-funded clinical trial for spinal cord injury reports promising results
Today, the Menlo Park-based biotech company Asterias Biotherapeutics reported positive results from the first three patients treated in its Phase 1/2a clinical study using stem cell therapy to treat patients with spinal cord injury. This trial is funded by a CIRM Strategic Partnerships Award grant of $14.3 million. Asterias has developed a stem cell therapy … Continue reading CIRM-funded clinical trial for spinal cord injury reports promising results
The Stem Cellar 